The rise of Sildenafil initially sparked a period of growth for major pharmaceutical companies, however recent shifts present a murky scenario for shareholders. Generic alternatives are eating into revenue, and ongoing https://saadkxbd133525.blogitright.com/41522924/viagra-and-pharma-a-risky-play